CDK4/6 Inhibition as Maintenance and Combination Therapy for High Grade Serous Ovarian Cancer
Oncotarget - United States
doi 10.18632/oncotarget.24585
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 26, 2018
Authors
Publisher
Impact Journals, LLC